Related references
Note: Only part of the references are listed.EDP-938, a Respiratory Syncytial Virus Inhibitor, in a Human Virus Challenge
Alaa Ahmad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Regulatory B cells, A to Z
Kirstin Jansen et al.
ALLERGY (2021)
EDP-938, a novel nucleoprotein inhibitor of respiratory syncytial virus, demonstrates potent antiviral activities in vitro and in a non-human primate model
Michael H. J. Rhodin et al.
PLOS PATHOGENS (2021)
The specific features of the developing T cell compartment of the neonatal lung are a determinant of respiratory syncytial virus immunopathogenesis
Thomas Demoulins et al.
PLOS PATHOGENS (2021)
Respiratory Syncytial Virus Disease Severity Is Associated with Distinct CD8+ T-Cell Profiles
David T. Siefker et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
Design and synthesis of 2-((1H-indol-3-yl)thio)-N-phenyl-acetamides as novel dual inhibitors of respiratory syncytial virus and influenza virus A
Guo-Ning Zhang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Neutrophils do not impact viral load or the peak of disease severity during RSV infection
Freja Kirsebom et al.
SCIENTIFIC REPORTS (2020)
Double-edged role of natural killer cells during RSV infection
Rauf Bhat et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2020)
Discovery of 3-({5-Chloro-1-[3-(methylsulfonyl)propyl]-1H-indol-2-yl}methyl)-1-(2,2,2-trifluoroethyl)-1,3-dihydro-2H-imidazo[4,5-c]pyridin-2-one (JNJ-53718678), a Potent and Orally Bioavailable Fusion Inhibitor of Respiratory Syncytial Virus
Sandrine Vendeville et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Updated cost-effectiveness analysis of palivizumab (Synagis) for the prophylaxis of respiratory syncytial virus in infant populations in the UK
Omendra Narayan et al.
JOURNAL OF MEDICAL ECONOMICS (2020)
Role of γδ T cells in controlling viral infections with a focus on influenza virus: implications for designing novel therapeutic approaches
Ailar Sabbaghi et al.
VIROLOGY JOURNAL (2020)
Respiratory Syncytial Virus Infects Primary Neonatal and Adult Natural Killer Cells and Affects Their Antiviral Effector Function
Elisabeth A. van Erp et al.
JOURNAL OF INFECTIOUS DISEASES (2019)
New therapies for acute RSV infections: where are we?
Ying Xing et al.
EUROPEAN JOURNAL OF PEDIATRICS (2019)
Small molecule inhibits respiratory syncytial virus entry and infection by blocking the interaction of the viral fusion protein with the cell membrane
Wei Tang et al.
FASEB JOURNAL (2019)
Late therapeutic intervention with a respiratory syncytial virus L-protein polymerase inhibitor, PC786, on respiratory syncytial virus infection in human airway epithelium
Daniel W. Brookes et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
T-Cell Responses in Adults During Natural Respiratory Syncytial Virus Infection
D. Roumanes et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Development of an allosteric inhibitor class blocking RNA elongation by the respiratory syncytial virus polymerase complex
Robert M. Cox et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Differential lower airway dendritic cell patterns may reveal distinct endotypes of RSV bronchiolitis
Aoife Kerrin et al.
THORAX (2017)
RSV Takes Control of Neonatal Breg Cells: Two Hands on the Wheel
Peter J. M. Openshaw
IMMUNITY (2017)
Dendritic Cells Display Subset and Tissue-Specific Maturation Dynamics over Human Life
Tomer Granot et al.
IMMUNITY (2017)
Respiratory Syncytial Virus Infects Regulatory B Cells in Human Neonates via Chemokine Receptor CX3CR1 and Promotes Lung Disease Severity
Dania Zhivaki et al.
IMMUNITY (2017)
The antiviral effects of RSV fusion inhibitor, MDT-637, on clinical isolates, vs its achievable concentrations in the human respiratory tract and comparison to ribavirin
Young-In Kim et al.
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2017)
Respiratory Syncytial Virus (RSV) Infects CD4+ T Cells: Frequency of Circulating CD4+ RSV+ T Cells as a Marker of Disease Severity in Young Children
Silvina Raiden et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Natural killer T cell sensitization during neonatal respiratory syncytial virus infection induces eosinophilic lung disease in re-infected adult mice
Seung Young Lee et al.
PLOS ONE (2017)
Respiratory syncytial virus (RSV) entry is inhibited by serine protease inhibitor AEBSF when present during an early stage of infection
Winke Van der Gucht et al.
VIROLOGY JOURNAL (2017)
Therapeutic efficacy of a respiratory syncytial virus fusion inhibitor
Dirk Roymans et al.
NATURE COMMUNICATIONS (2017)
Preclinical Characterization of PC786, an Inhaled Small-Molecule Respiratory Syncytial Virus L Protein Polymerase Inhibitor
Matthew Coates et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Neutrophil extracellular traps cause airway obstruction during respiratory syncytial virus disease
Bart Cortjens et al.
JOURNAL OF PATHOLOGY (2016)
Potential Role of Gut Microbial Metabolites in Allergy Prevention in Children
Caroline Roduit et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Alveolar Macrophages Can Control Respiratory Syncytial Virus Infection in the Absence of Type I Interferons
Spyridon Makris et al.
JOURNAL OF INNATE IMMUNITY (2016)
CX3CR1 is an important surface molecule for respiratory syncytial virus infection in human airway epithelial cells
Tatiana Chirkova et al.
JOURNAL OF GENERAL VIROLOGY (2015)
Discovery of Imidazopyridine Derivatives as Highly Potent Respiratory Syncytial Virus Fusion Inhibitors
Song Feng et al.
ACS MEDICINAL CHEMISTRY LETTERS (2015)
Impaired gamma delta T cell-derived IL-17A and inflammasome activation during early respiratory syncytial virus infection in infants
Huaqiong Huang et al.
IMMUNOLOGY AND CELL BIOLOGY (2015)
Epidemiological Characteristics and Immune Status of Children With Respiratory Syncytial Virus
Qing Ye et al.
JOURNAL OF MEDICAL VIROLOGY (2015)
Respiratory syncytial virus (RSV) and its propensity for causing bronchiolitis
Raymond J. Pickles et al.
JOURNAL OF PATHOLOGY (2015)
Antiviral Activity of TMC353121, a Respiratory Syncytial Virus (RSV) Fusion Inhibitor, in a Non-Human Primate Model
Gabriela Ispas et al.
PLOS ONE (2015)
Lower number of plasmacytoid dendritic cells in peripheral blood of children with bronchiolitis following respiratory syncytial virus infection
Kaizhi Weng et al.
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2014)
Current progress in antiviral strategies
Zhiyong Lou et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2014)
Differential Roles of Lung Dendritic Cell Subsets Against Respiratory Virus Infection
Tae Hoon Kim et al.
Immune Network (2014)
Regulatory T Cells Prevent Th2 Immune Responses and Pulmonary Eosinophilia during Respiratory Syncytial Virus Infection in Mice
Lydia R. Durant et al.
JOURNAL OF VIROLOGY (2013)
Distribution of Respiratory Syncytial Virus Subtypes A and B Among Infants Presenting to the Emergency Department With Lower Respiratory Tract Infection or Apnea
Hasan S. Jafri et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2013)
Local IL-17A Potentiates Early Neutrophil Recruitment to the Respiratory Tract during Severe RSV Infection
Arie Jan Stoppelenburg et al.
PLOS ONE (2013)
Respiratory Syncytial Virus Induced Type I IFN Production by pDC Is Regulated by RSV-Infected Airway Epithelial Cells, RSV-Exposed Monocytes and Virus Specific Antibodies
Marcel A. Schijf et al.
PLOS ONE (2013)
RSV infection modulates IL-15 production and MICA levels in respiratory epithelial cells
M. T. Zdrenghea et al.
EUROPEAN RESPIRATORY JOURNAL (2012)
Natural Killer Cells Are Involved in Acute Lung Immune Injury Caused by Respiratory Syncytial Virus Infection
Fengqi Li et al.
JOURNAL OF VIROLOGY (2012)
IL-17-Induced Pulmonary Pathogenesis during Respiratory Viral Infection and Exacerbation of Allergic Disease
Sumanta Mukherjee et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Antiviral and lung protective activity of a novel respiratory syncytial virus fusion inhibitor in a mouse model
W. Olszewska et al.
EUROPEAN RESPIRATORY JOURNAL (2011)
Respiratory syncytial virus disease: update on treatment and prevention
Leonard R. Krilov
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2011)
Central role of dendritic cells in shaping the adaptive immune response during respiratory syncytial virus infection
Daniel S. McDermott et al.
FUTURE VIROLOGY (2011)
Multiple CD4+ T Cell Subsets Produce Immunomodulatory IL-10 During Respiratory Syncytial Virus Infection
Kayla A. Weiss et al.
JOURNAL OF IMMUNOLOGY (2011)
Autocrine Regulation of Pulmonary Inflammation by Effector T-Cell Derived IL-10 during Infection with Respiratory Syncytial Virus
Jie Sun et al.
PLOS PATHOGENS (2011)
Alternative Activation of Macrophages: Mechanism and Functions
Siamon Gordon et al.
IMMUNITY (2010)
Foxp3+ CD4 Regulatory T Cells Limit Pulmonary Immunopathology by Modulating the CD8 T Cell Response during Respiratory Syncytial Virus Infection
Ross B. Fulton et al.
JOURNAL OF IMMUNOLOGY (2010)
Respiratory Virus-Induced TLR7 Activation Controls IL-17-Associated Increased Mucus via IL-23 Regulation
Nicholas W. Lukacs et al.
JOURNAL OF IMMUNOLOGY (2010)
A Systemic Neutrophil Response Precedes Robust CD8+ T-Cell Activation during Natural Respiratory Syncytial Virus Infection in Infants
Michael V. Lukens et al.
JOURNAL OF VIROLOGY (2010)
CD25+ Natural Regulatory T Cells Are Critical in Limiting Innate and Adaptive Immunity and Resolving Disease following Respiratory Syncytial Virus Infection
Debbie C. P. Lee et al.
JOURNAL OF VIROLOGY (2010)
Control of RSV-induced lung injury by alternatively activated macrophages is IL-4Rα-, TLR4-, and IFN-β-dependent
K. A. Shirey et al.
MUCOSAL IMMUNOLOGY (2010)
Respiratory Syncytial Virus Activates Innate Immunity through Toll-Like Receptor 2
Matthew R. Murawski et al.
JOURNAL OF VIROLOGY (2009)
Differential Recruitment of Dendritic Cells and Monocytes to Respiratory Mucosal Sites in Children with Influenza Virus or Respiratory Syncytial Virus Infection
Michelle A. Gill et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Alveolar macrophages are a major determinant of early responses to viral lung infection but do not influence subsequent disease development
Philippa K. Pribul et al.
JOURNAL OF VIROLOGY (2008)
The histopathology of fatal untreated human respiratory syncytial virus infection
Joyce E. Johnson et al.
MODERN PATHOLOGY (2007)
Respiratory syncytial virus infection of monocyte-derived dendritic cells decreases their capacity to activate CD4 T cells
PAA de Graaff et al.
JOURNAL OF IMMUNOLOGY (2005)
Antiviral activity and molecular mechanism of an orally active respiratory syncytial virus fusion inhibitor
C Cianci et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenase
P Leyssen et al.
JOURNAL OF VIROLOGY (2005)
Increased Toll-like receptor 4 expression in infants with respiratory syncytial virus bronchiolitis
A Gagro et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2004)
Orally active fusion inhibitor of respiratory syncytial virus
C Cianci et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
New drugs and treatment for respiratory syncytial virus
K Maggon et al.
REVIEWS IN MEDICAL VIROLOGY (2004)
Respiratory syncytial virus infection suppresses IFN-γ production of γδ T cells
M Aoyagi et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2003)
RSV entry inhibitors block F-protein mediated fusion with model membranes
V Razinkov et al.
ANTIVIRAL RESEARCH (2002)
RFI-641, a potent respiratory syncytial virus inhibitor
CC Huntley et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
RFI-641 inhibits entry of respiratory syncytial virus via interactions with fusion protein
V Razinkov et al.
CHEMISTRY & BIOLOGY (2001)
A comparison of cytokine responses in respiratory syncytial virus and influenza A infections in infants
RYT Sung et al.
EUROPEAN JOURNAL OF PEDIATRICS (2001)
Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus
EA Kurt-Jones et al.
NATURE IMMUNOLOGY (2000)
Share Paper
